Home  >  News
  Sancilio Pharma's Altemia receives US FDA rare pediatric disease status for treatment of SCDi n children,   September 21, 2017
  Arkis BioSciences' CerebroFlo EVD catheter with Endexo technology receives US FDA approval,   September 21, 2017
  Absorption Systems ink research pact with US FDA to share data on modeling & simulation to improve development of veterinary, human drugs,   September 21, 2017
  WHO report shows world is running out of antibiotics,   September 21, 2017
  Study shows exposure to pet and pest allergens during infancy linked to reduced asthma risk,   September 20, 2017
  Novartis' Rydapt gets EU approval for newly diagnosed FLT3-mutated acute AML & 3 types of advanced SM,   September 20, 2017
  Russia and India embark on transfer of technologies of drugs production for treatment of HIV infection,   September 20, 2017
  Inovio, Partners begin phase 1/2a trial to advance its vaccine against deadly MERS infection,   September 20, 2017
  Strides Shasun receives US FDA approval for generic Lovaza,   September 20, 2017
  Pfizer announces outcome of FDA committee meeting for Sutent in patients at high risk of recurrent RCC after surgery,   September 20, 2017
  Pharnext amends protocol of international pivotal phase 3 trials of PXT3003 for Charcot-Marie-Tooth disease type 1A,   September 20, 2017
  Sun Pharma's subsidiary gets US FDA approval for new label for Odomzo to treat patients with locally advanced basal cell carcinoma,   September 20, 2017
  Glenmark Pharma receives US FDA approval for generic Nitrostat sublingual tablets,   September 20, 2017
  Biocon’s Vishakhapatnam API facility completes US FDA inspection,   September 20, 2017
  EMA committee issues positive opinion for an update of SmPC for Pradaxa,   September 20, 2017
  Eurofins to acquire global scientific services company, EAG Laboratories,   September 20, 2017
  Thrombolytic Science completes phase 1 trial of novel clot-dissolving therapy, TS01,   September 20, 2017
  AbbVie reports positive results from phase 3 trial of Venclexta/Venclyxto in combo with Rituxan to treat patients with relapsed/refractory CLL,   September 20, 2017
  WHO launches new Noncommunicable disease Progress Monitor 2017,   September 19, 2017
  US FDA approves once-daily single inhaler triple therapy, Trelegy Ellipta to treat patients with COPD,   September 19, 2017

Copyright © 2016 Saffron Media Pvt. Ltd |